Unregistered Pharmaceuticals, their Use and Approval of Payment from Public Health Insurance

Czech version

Authors: H. Vlčková
Authors‘ workplace: OP VZP hl. m. Prahy
Published in: Listy rev. Lék., 9, 2005, č. 1, s. 14-16

Overview

The paper presents the comparison of expenditure on unregistered pharmaceuticals in the second quarter of the year 2003 and 2004: high expenses on pharmaceuticals used for a long time and so far unregistered, newly introduced pharmaceuticals, increasing proportion of pharmaceuticals in which the registration was not renewed after their validity was finished.

Key words:
approval of unregistered pharmaceuticals by the physician reviewer – par. 16 of the law No. 48/1997 – annual increase of cost

Labels

Medical assessment Occupational medicine

The Category of a Patient: the Problem from the Perspective of the Revision Medical Officer

Problems of a Rational Therapy: Part One

The Issue of the Reduction of Duration of Stay in a Spa Facility in a Child with a Complicated Health Status

The Physician Reviewer as an Actor of Multiple Roles

The Service Life and Period of Guarantee of Stomatologic Products

Article was published in

Revision Medicine Journal

2005 Issue 1